Dasabuvir
Showing 26 - 50 of 88
ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic
Completed
- Chronic Hepatitis C
- (no location specified)
May 1, 2019
Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in
Completed
- Chronic Hepatitis C, Genotype 1 or 4
- (no location specified)
Feb 6, 2019
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hepatitis C, Chronic Trial in Sydney ("3D" regimen, "3D" regimen with ribavirin)
Completed
- Hepatitis C, Chronic
- "3D" regimen
- "3D" regimen with ribavirin
-
Sydney, New South Wales, AustraliaThe Kirby Institute, University of New South Wales Australia
Jun 11, 2019
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic
Completed
- Chronic Hepatitis C
- (no location specified)
Mar 26, 2019
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic
Completed
- Chronic Hepatitis C
- (no location specified)
Oct 22, 2018
Viekira/Exviera for Korean Hepatitis C Patients According to
Completed
- Hepatitis C Virus (HCV)
-
Busan, Busan Gwang Yeogsi, Korea, Republic of
- +58 more
Oct 6, 2020
Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir
Completed
- Kidney Transplant
- +2 more
- Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
- Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
-
Columbus, OhioBrenda Cuson
Jul 29, 2021
Chronic Hepatitis C Trial (paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin)
Completed
- Chronic Hepatitis C
- paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin
- (no location specified)
Oct 17, 2018
Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks
Completed
- Hepatitis C Infection
- ombitasvir/paritaprevir/ritonavir 8 weeks
- dasabuvir 8 weeks
-
Barcelona, SpainCarrion, Jose Antonio, PhD
May 18, 2018
Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in
Completed
- Chronic Hepatitis C
-
Marseille CEDEX 08, Bouches-du-Rhone, France
- +69 more
Mar 13, 2019
Chronic Kidney Disease, Chronic Hepatitis C Trial in Boston (Viekira Pak ± ribavirin, Mavyret)
Completed
- Chronic Kidney Disease
- Chronic Hepatitis C
- Viekira Pak ± ribavirin
- Mavyret
-
Boston, MassachusettsMassachusetts General Hospital
Oct 5, 2021
RIBAvirin Plasma COncentrations in Chronic Hepatitis C Infection
Completed
- HCV Coinfection
- Hepatitis C
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
Dec 4, 2020
Chronic Hepatitis C Virus (HCV) Trial (ABT-450/r/ABT-267, ABT-333, ribavirin)
Completed
- Chronic Hepatitis C Virus (HCV)
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Feb 27, 2018
Chronic Hepatitis C Infection Trial in United States (ABT-267, ABT-450, ABT-333)
Chronic Hepatitis C Infection Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, Sofosbuvir, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ombitasvir/paritaprevir/ritonavir and dasabuvir
- +2 more
- (no location specified)
Nov 22, 2017